Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. 1989

M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
Second Department of Internal Medicine, Chiba University School of Medicine, Inohana, Japan.

The insulin receptor has an intrinsic tyrosine kinase activity that is essential for signal transduction. A mutant insulin receptor gene lacking almost the entire kinase domain has been identified in an individual with type A insulin resistance and acanthosis nigricans. Insulin binding to the erythrocytes or cultured fibroblasts from this individual was normal. However receptor autophosphorylation and tyrosine kinase activity toward an exogenous substrate were reduced in partially purified insulin receptors from the proband's lymphocytes that had been transformed by Epstein-Barr virus. The insulin resistance associated with this mutated gene was inherited by the proband from her mother as an apparently autosomal dominant trait. Thus a deletion in one allele of the insulin receptor gene may be at least partly responsible for some instances of insulin-resistant diabetes.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females

Related Publications

M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
July 1989, Science (New York, N.Y.),
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
April 1992, Diabetes,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
January 1994, Nature,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
December 1992, Biochemical and biophysical research communications,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
August 1993, Biochemical Society transactions,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
October 1991, The Journal of clinical endocrinology and metabolism,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
August 1992, Biochemical Society transactions,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
May 1993, Diabetologia,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
January 1991, Endocrinology,
M Taira, and M Taira, and N Hashimoto, and F Shimada, and Y Suzuki, and A Kanatsuka, and F Nakamura, and Y Ebina, and M Tatibana, and H Makino
March 1993, Molecular and cellular biochemistry,
Copied contents to your clipboard!